ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,769.40
0.00%
S&P ASX All Technology
3,070.80
-0.59%
Brent Oil
84.72
0.03%
US Dollar vs AUD
1.49813
0.00%
Bitcoin
66,390.78
2.19%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Ginkgo Bioworks Holdings Inc (DNA)

  7. Ginkgo Bioworks Holdings Inc (DNA) News

DNA Ginkgo Bioworks Holdings Inc

0.425
0.004 (0.95%)
Pre Market
Last Updated: 21:12:15
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Ginkgo Bioworks Holdings Inc DNA NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.004 0.95% 0.425 21:12:15
Open Price Low Price High Price Close Price Previous Close
0.421
more quote information »

Recent News

Date Time Source Heading
19/6/202400:26EDGAR2Form 144 - Report of proposed sale of securities
15/6/202406:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/6/202406:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/6/202406:07EDGAR2Form 8-K - Current report
14/6/202400:14EDGAR2Form 144 - Report of proposed sale of securities
13/6/202400:31EDGAR2Form 144 - Report of proposed sale of securities
12/6/202400:43EDGAR2Form 144 - Report of proposed sale of securities
11/6/202400:33EDGAR2Form 144 - Report of proposed sale of securities
08/6/202400:15EDGAR2Form 144 - Report of proposed sale of securities
07/6/202400:03EDGAR2Form 144 - Report of proposed sale of securities
06/6/202407:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202407:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202400:25EDGAR2Form 144 - Report of proposed sale of securities
05/6/202400:08EDGAR2Form 144 - Report of proposed sale of securities
04/6/202405:39EDGAR2Form 144 - Report of proposed sale of securities
04/6/202404:08EDGAR2Form 144 - Report of proposed sale of securities
01/6/202401:39EDGAR2Form 144 - Report of proposed sale of securities
31/5/202400:58EDGAR2Form 144 - Report of proposed sale of securities
30/5/202400:45EDGAR2Form 144 - Report of proposed sale of securities
29/5/202400:18EDGAR2Form 144 - Report of proposed sale of securities
25/5/202400:22EDGAR2Form 144 - Report of proposed sale of securities
24/5/202400:02EDGAR2Form 144 - Report of proposed sale of securities
22/5/202423:44EDGAR2Form 144 - Report of proposed sale of securities
22/5/202401:02EDGAR2Form 144 - Report of proposed sale of securities
21/5/202400:43EDGAR2Form 144 - Report of proposed sale of securities
20/5/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
18/5/202406:50EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/5/202400:24EDGAR2Form 144 - Report of proposed sale of securities
17/5/202400:31EDGAR2Form 144 - Report of proposed sale of securities
16/5/202403:24EDGAR2Form 144 - Report of proposed sale of securities
15/5/202421:01PRNUSGinkgo Bioworks to Participate in Two Conferences in May
15/5/202408:00PRNUSSojitz Corporation and Ginkgo Bioworks Announce Plans to Use..
15/5/202400:48EDGAR2Form 144 - Report of proposed sale of securities
14/5/202406:14EDGAR2Form 8-K - Current report
14/5/202406:05PRNUSGinkgo Bioworks Receives Continued Listing Standard Notice..
14/5/202400:50EDGAR2Form 144 - Report of proposed sale of securities
11/5/202400:10EDGAR2Form 144 - Report of proposed sale of securities
10/5/202407:16EDGAR2Form S-3 - Registration statement under Securities Act of..
10/5/202406:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202406:02EDGAR2Form 8-K - Current report
10/5/202406:01PRNUSGinkgo Bioworks Reports First Quarter 2024 Financial Results
10/5/202400:13EDGAR2Form 144 - Report of proposed sale of securities
09/5/202400:43EDGAR2Form 144 - Report of proposed sale of securities
08/5/202401:40EDGAR2Form 144 - Report of proposed sale of securities
07/5/202421:01PRNUSGreenLab Partners with Ginkgo Bioworks to Scale Up..
07/5/202406:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202406:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202400:43EDGAR2Form 144 - Report of proposed sale of securities
06/5/202421:01PRNUSGinkgo Bioworks Announces Presentations at the Upcoming..
02/5/202421:00PRNUSGinkgo Bioworks Announces Date of First Quarter 2024 Results..

Your Recent History

NYSE
DNA
Ginkgo Bioworks
BIT
F33781
Vontobel Financial Produ...
LSE
44VD
Barclays 25
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved